Keyphrases
Neuroendocrine Tumor
100%
Peptide Receptor Radionuclide Therapy
100%
Somatostatin Receptor Imaging
75%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
50%
Nuclear Imaging
50%
PET Tracer
50%
Somatostatin Receptor
50%
Tumor
50%
Duration of Response
25%
123I-MIBG
25%
Complete Response
25%
Diagnostic Work-up
25%
18F-DOPA
25%
Somatostatin Analogs
25%
Tumor Patients
25%
177Lu-DOTATATE
25%
Partial Response
25%
Nonrandomized Studies
25%
Kidney
25%
Gamma Camera
25%
Radionuclides
25%
Therapy Planning
25%
Bone Marrow Toxicity
25%
Medicine and Dentistry
Neuroendocrine Tumor
100%
Somatostatin Receptor
100%
Polyethylene Terephthalate
83%
Radioactive Tracer
83%
Peptide Receptor
66%
Radionuclide Therapy
66%
Gallium 68
50%
Neoplasm
33%
Bone Marrow Toxicity
16%
Pentetic Acid
16%
Spine
16%
Carbon 11
16%
Nuclear Medicine
16%
Iodine 123
16%
Radioisotope
16%
Gamma Camera
16%
Nuclear Imaging
16%
Lutetium 177
16%
Therapy Planning
16%
DOPA
16%
Diagnosis
16%
Somatostatin Derivative
16%
Single-Photon Emission Computed Tomography
16%
Indium 111
16%
Octreotide
16%
Fluorine-18
16%